Advertisement

Related Videos

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Welcome and Introduction to Vi3C

Advertisement

Advertisement




Dec
03
Today In Oncology
Pharmacokinetic Comparison of Aumolertinib Osimertinib Gefitinib and Their Major Metabolites in NSCLC
MRD-Guided Chemotherapy Intensification After Induction in Fit Older Patients With AML
Study May Illuminate Cause of Common Checkpoint Inhibitor Adverse Effect
Radiotherapy With Durvalumab or Cetuximab in Locoregionally Advanced Head and Neck Cancer With Contraindication for Cisplatin
Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1–Associated Plexiform Neurofibroma
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Conexiant Oncology Logo